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VITAMIN A AND LIPID PEROXIDATION IN PATIENTS WITH DIFFERENT FORMS OF LEPROSY
Emerson S. LIMA(1), Ivete de A. ROLAND(2), Maria de Fátima MAROJA(3) & Jaydione L. MARCON(4)
SUMMARY
Leprosy, a chronic infectious disease, is caused by a Mycobacterium leprae infection. After India, Brazil has the second
greatest number of cases in the world. Increase of oxidative stress and antioxidant deficiency are present in infected subjects and
can be related to infection progression. We studied alterations in serum levels of lipid peroxidation (LPO) and vitamin A in
patients with different forms of leprosy. Four groups of leprosy patients and a control group (healthy subjects) were selected, and
their vitamin A serum levels and LPO profile, measured as malonaldehyde (MDA) were measured by spectrophotometric
assays. The mean MDA serum levels (µmol/L) were 3.80 ± 0.5 for control group and 10.54 ± 1.1 in the leprosy patients and this
increase was gradual, being more accentuated in severe forms of the disease. Also, the vitamin A serum levels (µg/dL) were
diminished in the infected subjects (38.51 ± 4.2), mainly in lepromatous form, when compared with the control group (53.8 ± 5.6).
These results indicate that LPO can be an important factor in Mycobacterium leprae infection, which can be related to increases in
phagocytic activity and the general breakdown of antioxidants, contributing to an increase of LPO during infection progression.
The evaluation of oxidant/antioxidant status in these patients can be an important factor in the treatment, control, and/or prognosis
of this disease.
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INTRODUCTION
Leprosy or Hansen disease is caused by an infection by
Mycobacterium leprae. Brazil has the second greatest number of cases
in the world after India. The World Health Organization initially set a
target goal for eliminating the disease world-wide by the year 2000,
yet this date was postponed to 2005 and has still not been obtained by
Brazil.
M. leprae is an obligatory intracellular parasite with affinity for
the cells of Schwann and the reticuloendothelial system, mainly
macrophages15. In leprosy patients, the development of the infection
depends upon the quality of the immunological response. If the response
is effective, the infection will produce a non-contagious localized
expression of the disease; however, if the response is not effective, an
intermediate form develops, reflecting a wide spectrum of resistance4.
The defense mechanism has primordial participation of the
macrophages, lymphocytes, and its cytokines, regulating the production,
release and modulation of diverse and important cellular immunity
reactions. In the tuberculoid form, this response is predominantly
cellular, while lepromatous typically shows a humoral defense4.
Several substances with recognized antioxidant potential, such as
retinol (vitamin A), α-tocopherol (vitamin E), acid ascorbic (vitamin
C), zinc, magnesium and selenium have been shown to decrease in
different forms of leprosy11,12,14,16. A decrease of antioxidant status can
contribute to an increase of oxidative stress and complicate the treatment
and the control of these patients. The measurement of malondialdehyde
(MDA) serum levels in association with the determination of the
antioxidant status can constitute an important tool in prognosis,
treatment, and control of leprosy patients or other degenerative
disease12.
In the present study, the serum levels of lipid peroxidation
(measured as MDA) and vitamin A were determined in patients with
the different forms of leprosy. These parameters were compared in
subjects with different forms of the disease and no leprosy.
MATERIAL AND METHODS
Patients: Forty-three patients attending the Foundation of
Dermatology and Venereology “Alfredo da Matta” (FUAM) were
selected and divided into four groups according to forms of leprosy:
Indeterminate (n = 11), tuberculoid (n = 12), borderline (n = 10) and
lepromatous (n = 10). The patients had clinical diagnosis, as previous
criteria6, and had not been previously submitted to drug treatment.
Also, healthy subjects (n = 11) were selected as control group.
Participants age varied between 20 and 60 years. Volunteers who were
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identified through a questionnaire as positive for other diseases were
excluded from the study. All the participants signed written informed
consent forms, authorizing the use of their samples in this study, which
was approved by the Ethics Committee for Human Research of the
FUAM.
Samples: Blood samples (5 mL) were collected from the cubital
vein in the morning. Subjects fasted for 12 h before sample collection.
The venous blood samples were centrifuged at 2500 rpm for 15 min.
The serum samples were then stored at -20 ºC until biochemical
analysis.
Analytical procedures
MDA test: MDA serum levels were determined by thiobarbituric
acid reactive substances (TBARs) assay, according to OHKAWA et
al.10, and 200 µL of serum was added and briefly mixed with 1 mL of
trichloroacetic acid at 30%, 0.9 mL of TRIS-HCl (pH 7.4), and 1 mL
of thiobarbituric acid 0.73%. After vortex mixing, samples were
maintained at 100 ºC for 60 minutes. Afterwards, samples were
centrifuged at 3000 rpm for 10 min and supernatant read at 535 ηm.
The signal was read against an MDA standard curve, and the results
were expressed as µmol/L.
Vitamin A measurement: The vitamin A serum levels were
determined by a spectrophotometric method with ultraviolet light
inactivation2. Briefly, after mixing 500 µL of serum with 500 µL of
alcoholic KOH, vitamin A was extracted by a coefficient of partition
in a kerosene-xylene mixture (2 mL). After centrifugation for 15
minutes at 3,000 rpm, the supernatant was read at 328 ηm. The
absorbance was proportional to vitamin A concentration in the sample.
The signal was read against a retinol standard curve and the results
were expressed as µg/dL.
Statistical analyses: All parameters were given as mean ± sd. Data
were analyzed statistically by ANOVA and by multiple comparisons
between groups (Tukey’s test). Correlations between MDA and vitamin
A were also examined by Pearson Correlation test. The tests were
performed using the SigmaStat 2.03 software (Jandel Scientific,
Chicago). Statistical significance for all tests was accepted at p < 0.05.
RESULTS
The MDA serum levels (mean ± sd in µmol/L) were 3.8 ± 0.5 in
control group, 9.8 ± 1.5 in undetermined, 10.1 ± 1.1 in tuberculoid,
10.1 ± 0.9 in borderline and 12.2 ± 1.0 in patients with lepromatous
form. MDA serum levels were increased with statistical significance
when this last group was compared with the control group. Thus, this
increase was gradual and corresponded to the different periods of
development of the disease, being more accentuated in the patients of
the lepromatous form (Fig. 1). The vitamin A serum levels (mean ± sd
in µg/dL) were 53.8 ± 5.6 in control group, 42.3 ± 7.0 in undetermined,
40.3 ± 6.2 in tuberculoid, 38.9 ± 6.2 in borderline and 32.5 ± 8.4 in
lepromatous form. In the leprosy patients, the vitamin A levels were
diminished in relation to the control group; however, only the
lepromatous form presented statistically significant lower levels of
vitamin A (Fig. 2). In addition, when vitamin A and MDA levels of the
patients with different forms of leprosy were compared through the
analysis of Pearson Correlation, an inverse correlation was shown
(p = 0.012, Fig. 3).
Fig. 1 - MDA serum levels (mean ± sd in µmol/L) in control subjects and leprosy patients. C
= control group (3.8 ± 0.5), I = indeterminate (9.8 ± 1.5), T = tuberculoid (10.1 ± 1.1), B =
borderline (10.1 ± 0.9), L = lepromatous (12.2 ± 1.0). (*) Statistically significant differences
vs. control group (p < 0.05)
Fig. 2 - Vitamin A serum levels (mean ± sd in µg/dL) in control subjects and leprosy patients.
C = control group (53.8 ± 5.6), I = indeterminate (42.3 ± 7.0), T = tuberculoid (40.3 ± 6.2),
B = borderline (38.9 ± 6.2), L = lepromatous (32.5 ± 8.4). (*) Statistically significant
differences vs. control group (p < 0.05).
Fig. 3 - Correlation between vitamin A (µg/dL) and MDA (µmol/L) serum levels in leprosy
patients. (Pearson correlation test, r = -0.421; p = 0.012; n = 35).




The antioxidant deficiency reported in the literature for different
forms of leprosy, mainly in the lepromatous form11, could be related to
the increase of the levels of MDA observed in the present work. It was
observed that the vitamin A levels in the serum of the leprosy patients,
mainly in the lepromatous form, diminished in relation to the control,
which is consistent with the literature11,12. As vitamin A is directly related
to maintenance of the cellular membrane structure, it is possible that the
reduction of vitamin A contributes to an increase in the production of
MDA in these individuals. Increased levels of MDA have also been found
in renal tissue of mice infected with M. leprae1. Also, some authors
have described an increase in phagocytic activity in leprosy3,15.
The induction of the macrophages in response to the infection of
the M. leprae could contribute to an increase in MDA levels since
phagocytosis is a potential mechanism in reactive oxygen species (ROS)
production3. This aspect can be physiologically important; however,
to intensify the production of the ROS, the macrophages are rendered
inefficient in eliminating bacilli in the borderline or lepromatous forms4.
This cascade of events could also be responsible for the increase of
MDA levels in the leprosy patients, mainly in the cases of the
lepromatous form, since the immunological response of the organism
is predominantly lymphocyte B dependent15. The inefficient action of
the macrophages on the M. leprae could increase the oxidative effects
on other cells of the host organism, as the erythrocytes and adjacent
tissues, contributing still more to the establishment of oxidative stress
in the patients with borderline (with variations) and lepromatous forms.
The increasing of MDA levels in different forms of the leprosy, mainly
in lepromatous form, could be interpreted as intensifying the oxidative
stress to which these patients are submitted.
On the other hand, leprosy is a disease of chronic evolution,
releasing cytokines in the circulation throughout the life span of infected
individuals. These substances inhibit the action of the 3-Hydroxy-3-
methylglutaryl coenzyme A reductase, an essential enzyme in the
synthesis of cholesterol from acid mevalonic. It is probable that, with
the reduction of the cholesterol synthesis, this enzyme reduced the
synthesis of very low density lipoprotein and low density lipoprotein
production, which are transporter of lipo-soluble vitamins, including
vitamin A7. This cascade of events could result in the reduction of
vitamin A levels in the serum, and this would explain, in part, the
reduction of vitamin A levels observed in the serum of the leprosy
patients. Vitamin A deficiency has been identified in leprosy patients
of other countries, such as India11, mainly in patients with more
accentuated forms5 and also in patients of the Amazon13. These results
were also confirmed in the present work, indicating the existence of a
possible functional relation between the levels of this vitamin and the
levels of MDA in the leprosy patients.
In conclusion, our results suggest that MDA serum levels increase
in leprosy patients in comparison with subjects with no leprosy, and
vitamin A serum levels were intensely reduced in lepromatous form of
this disease. Moreover, the reduction of this antioxidant, combined
with the impoverished social conditions as well as undernutrition found
in the majority of leprosy patients, may contribute to reducing the
success rate in the treatment and recovery of these patients. Moreover,
it is important to point out that none of the patients of this study used
specific treatment with drugs such as dapsone and clofazimine, which
can exacerbate oxidative stress8,9. The introduction of a diet or
antioxidant therapy supplemented by vitamins and minerals could be
beneficial for these patients, attenuating the toxic actions caused by
the ROS and propitiating an adjusted treatment and recovery, thus
possibly improving the quality of life of these subjects.
RESUMO
Vitamina A e peroxidação lipídica em pacientes com diferentes
formas de hanseníase
A hanseníase, doença infecciosa crônica, é causada pelo
Mycobacterium leprae. Depois da Índia, o Brasil possui o segundo
maior número de casos no mundo. O aumento do estresse oxidativo e
da deficiência das defesas antioxidantes estão presentes em indivíduos
infectados e podem associar-se à progressão da infecção. Foram
estudadas alterações nos níveis séricos da peroxidação lipídica e
vitamina A em pacientes com diferentes formas de hanseníase. Foram
selecionados para o estudo quatro grupos de pacientes com hanseníase
e um grupo controle (indivíduos saudáveis) e os níveis séricos de
vitamina A e a peroxidação lipídica, medida através do malondialdeído
(MDA), foram determinados por métodos espectrofotométricos. Os
níveis séricos médios de MDA (µmol/L) foram 3,80 ± 0,5 no grupo
controle e 10,54 ± 1,1 nos pacientes com hanseníase. Sendo este
aumento gradual e exacerbado nas formas mais severas da doença.
Quanto à vitamina A, os níveis séricos (µg/dL) encontraram-se
diminuídos nos indivíduos infectados (38.51 ± 4.2), principalmente na
forma lepromatosa, quando comparados com o grupo controle (53.8 ±
5.6). Estes resultados indicam que a peroxidação lipídica pode ser um
fator importante na infecção mediada pelo Mycobacterium leprae
podendo estar relacionada ao aumento da atividade fagocítica pelos
macrófagos contribuindo para um aumento da LPO durante a progressão
da infecção. A avaliação do perfil oxidante/antioxidante nestes pacientes
pode ser um fator importante no tratamento, controle e/ou prognóstico
desta doença.
ACKNOWLEDGMENTS
We would like thanks to Dra. Marina Helyde and Dra. Lúcia Kiyoko
Ozaki Yuyama for the contribution in the dosage of the vitamin A and
the team of the Laboratory of Experimental Nutrition in the National
Institute of Research of the Amazônia (INPA).
REFERENCES
1. AGNIHOTRI, N.; GANGULY, N.K.; KAUR, S. et al. - Role of reactive oxygen species
is renal damage in experimental leprosy. Lepr. Rev., 66: 201-209, 1995.
2. ARAÚJO, C.R.C. & FLORES, H. - Improved spectrophotometric vitamin A assay. Clin.
Chem., 24: 386-390, 1978.
3. BABIOR, B.M. - Oxidants from phagocytes: agents of defense and destruction. Blood,
64: 959-966, 1984.
4. BRITTON, W.J. - Immunology of leprosy. Trans. roy. Soc. trop. Med. Hyg., 87: 508-
514, 1993.
5. CHATTOPADHYA, D.; SAHA, K.; CHAKRABARTY, A.K. et al. - Nutritional status of
children of urban leprosy patients staying at preventoria based on biochemical
parameters. Europ. J. clin. Nutr., 46: 885-895, 1992.
214
LIMA, E.S.; ROLAND, I.A.; MAROJA, M.F. & MARCON, J.L. - Vitamin A and lipid peroxidation in patients with different forms of leprosy. Rev. Inst. Med. trop. S. Paulo, 49(4):211-214,
2007.
6. GATICA, L.V.; VEGA, V.A., ZIRULNIK, F.; OLIVEROS, L.B. & GIMENEZ, M.S. -
Alterations in the lipid metabolism of rat aorta: effects of vitamin A deficiency. J.
Vasc. Res., 43: 602-610, 2006.
7. JOPLING, W.H. - Handbook of leprosy. 2. ed. London, Heinemann, 1978.
8. LARDO, M.M.; DIAZ, N.B.; ARTAZA, J.R. et al . - Vitamin E as protective agent against
hemolysis in leprosy patients under dapsone treatment. Medicina (B. Aires), 57:150-
154, 1997.
9. McMILLAN, D.C.; JENSEN, C.B. & JOLLOW, D.J. - Role of lipid peroxidation in
dapsone-induced hemolytic anemia. J. Pharmacol. exp. Ther., 287: 868-876, 1998.
10. OHKAWA, H.; OHISHI, N. & YAGI, K. - Assay for lipid peroxides in animal tissues by
thiobarbituric acid reaction. Analyt. Biochem., 95: 351-358, 1979.
11. RAO, K.N. & SAHA, K. - Undernutrition and lepromatous leprosy. Serum vitamin A
and E levels in leprosy spectrum. Indian J. Lepr., 60: 66-70, 1988.
12. REDDY, Y.N.; MURTHY, S.V.; KRISHNA, D.R. et al. - Oxidative stress and anti-oxidant
status in leprosy patients. Indian J. Lepr., 75: 307-316, 2003.
13. SALEM, J.I.; FERRARI, I.; SOUZA, A.T.O. et al. - Transformação blástica em pacientes
hansenianos: correlação com vitamina A e zinco. Rev. Univ. Amaz. Ser. Cien. Saúde,
1: 63-70, 1992.
14. SAXENA, N.; SHARMA, R.P. & SINGH, V.S. - Study of serum zinc level in leprosy.
Indian J. Lepr., 60: 556-561, 1988.
15. SPIERINGS, E.; DE BOER, T.; ZULIANELLO, L. & OTTENHOFF, T.H. - The role of
Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of
nerve damage in leprosy. Lepr. Rev., 71(suppl.): S121-S129, 2000.
16. VIJAYARAGHAVAN, R.; SURIBABU, C.S.; SEKAR, B. et al. - Protective role of vitamin
E on the oxidative stress in Hansen’s disease (Leprosy) patients. Europ. J. clin.
Nutr., 59: 1121-1128, 2005.
Received: 12 September 2006
Accepted: 22 December 2006
